Serum levels of glycosyltransferases and related glycoproteins as indicators of cancer: biological and clinical implications.
Many studies have suggested that malignant transformation is associated with fundamental changes in the cell surface; similar changes have been described for normal stem cells and cells of embryonic or fetal origin. There is now evidence that the tumor cell secretes or sheds glycoproteins and glycosyltransferases into the surrounding medium and into serum. There are claims that some of these serum glycoproteins and glycosyltransferases are associated with, or specifically related to, the extent of tumor growth and may serve as a cancer marker. A cancer-associated galactosyltransferase isoenzyme (GT-II) has been described and purified. Different isoelectric forms of fucosyltransferase have also been described as indicative of malignancy. The articles to be published in CRC Critical Reviews in Clinical Laboratory Sciences will analyze the evidence for the association of these membrane factors with tumor growth. In order to better understand the possible significance of altered glycoproteins and of increased or different forms of glycosyltransferases during tumor growth, recent data on glycoprotein synthesis will be discussed including the new concepts on the control of glycoprotein synthesis through lipid intermediates. The possible mechanisms whereby malignant transformation could alter glycoprotein synthesis will be discussed with particular emphasis on the significance of these alterations to the biology of the malignant cell. Changes in surface membrane glycoproteins have long been implicated in the ability of a cell to metastasize. Secretion and/or shedding of the cell surface may also be important in the process of metastasis and in altering the host immune response. Detection and the study of these "shed" materials in patients appear to be indicating a new approach to cancer biology detection and therapy.
D000818:Animals; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D004195:Disease Models, Animal; D005647:Fucosyltransferases / Q000097:blood / Q000378:metabolism; D005700:Galactosyltransferases / Q000097:blood / Q000378:metabolism; D005964:Glucosyltransferases / Q000097:blood*; D006023:Glycoproteins / Q000096:biosynthesis / Q000097:blood*; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008565:Membrane Proteins / Q000378:metabolism; D009369:Neoplasms / Q000097:blood*; D009844:Oligosaccharides / Q000378:metabolism; D012799:Sialyltransferases / Q000097:blood / Q000378:metabolism
D006023:Glycoproteins; D007527:Isoenzymes; D008565:Membrane Proteins; D009844:Oligosaccharides; D005647:Fucosyltransferases; D005700:Galactosyltransferases; D005964:Glucosyltransferases; D012799:Sialyltransferases